[Aminophenazone half life in patients with chronic liver parenchyma disorders].
D000632:Aminopyrine / Q000097:blood / Q000378:metabolism*; D000818:Animals; D000983:Antipyrine / Q000652:urine; D002908:Chronic Disease; D005234:Fatty Liver / Q000378:metabolism; D005260:Female; D006207:Half-Life; D006505:Hepatitis / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism*; D008297:Male; D008862:Microsomes, Liver; D008875:Middle Aged; D051381:Rats
D000632:Aminopyrine; D000983:Antipyrine
Aminophenazonhalbwertszeit bei Patienten mit chronischen Leberparenchymachäden.